John hancock expands access to galleri®, grail's breakthrough cancer screening technology

Carrier previously became the first life insurer to offer access to the galleri test through a pilot in 2022 tsx/nyse/pse: mfc sehk: 945 boston , feb. 23, 2023 /prnewswire/ -- today, john hancock , a unit of manulife (nyse: mfc), announced it will expand access to grail's galleri® multi-cancer early detection test to eligible life insurance customers participating in the john hancock vitality plus program, a significant milestone in john hancock's ongoing efforts to help customers live longer, healthier, better lives. the expanded access comes after john hancock became the first life insurance carrier to make the breakthrough screening technology available to a pilot group of customers in september 2022.
MFC Ratings Summary
MFC Quant Ranking